Effect of Citicoline in Bipolar Disorder in current manic epiode

Not Applicable

• Conditions: Bipolar Disorder manic episode.; Bipolar Disorder, current episode manic severe with psychotic features; F31.2

• Registration Number: IRCT20090304001743N17
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Young Mania Rating Scale greater than or equal to 20
Consent agreement to participate in the study
Hospital Admission due to psychiatrist opinion
Age greater than or equal to 16

Exclusion Criteria

Psychiatric disorders except Bipolar 1 Disorder
Not to have medical disease
Citicolin Contraindication

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effectiveness of Citicoline on reduction of mania episode in bipolar patients administered by YMRS. Timepoint: Assessment of mania status administered by Young Mania Rating Scale at the first date of hospitalization, and the first and second week of receiving Citicoline. Method of measurement: Young Mania Rating Scale.

Secondary Outcome Measures

Name	Time	Method
The reduction of mania symptoms. Timepoint: At the start of the study and the first and second week after receiving citicolin. Method of measurement: Young Mania Rating Scale (YMRS).